Publication | Open Access
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
26
Citations
74
References
2021
Year
These findings identify efficacious and potentially safe tumor-targeting of SLC3A2 with novel immune-activating antibody and genetically modified cell therapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1